203 related articles for article (PubMed ID: 26809941)
1. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
[TBL] [Abstract][Full Text] [Related]
2. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
4. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
Shiferaw F; Letebo M; Bane A
BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries.
Ortiz E; Scanlon B; Mullens A; Durham J
J Community Health; 2020 Feb; 45(1):201-218. PubMed ID: 31332639
[TBL] [Abstract][Full Text] [Related]
6. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
[TBL] [Abstract][Full Text] [Related]
7. More than a virus: a qualitative study of the social implications of hepatitis B infection in China.
Wallace J; Pitts M; Liu C; Lin V; Hajarizadeh B; Richmond J; Locarnini S
Int J Equity Health; 2017 Aug; 16(1):137. PubMed ID: 28764768
[TBL] [Abstract][Full Text] [Related]
8. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
[TBL] [Abstract][Full Text] [Related]
9. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
10. European guideline for the management of hepatitis B and C virus infections, 2010.
Brook G; Soriano V; Bergin C
Int J STD AIDS; 2010 Oct; 21(10):669-78. PubMed ID: 21139144
[TBL] [Abstract][Full Text] [Related]
11. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research.
Li T; Su S; Zhao Y; Deng R; Fan M; Wang R; Sharma M; Zeng H
Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30650581
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
Hopf U; Niederau C; Kleber G; Fleig WE
Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
[No Abstract] [Full Text] [Related]
13. [Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Maier KP
Praxis (Bern 1994); 2003 Aug; 92(33):1351-7. PubMed ID: 14502791
[TBL] [Abstract][Full Text] [Related]
14. How to improve access to therapy in hepatitis B patients.
Subic M; Zoulim F
Liver Int; 2018 Feb; 38 Suppl 1():115-121. PubMed ID: 29427482
[TBL] [Abstract][Full Text] [Related]
15. [Challenges in accessing treatment for chronic hepatitis B in Madagascar : A qualitative study of caregivers and patients].
Mattern C; Pourette D; Andriamandimby SF; Rabarison J; Darsot A; Ralaizara B; Vray M; Shimakawa Y; Giles-Vernick T
Rev Epidemiol Sante Publique; 2023 Aug; 71(4):102088. PubMed ID: 37352795
[TBL] [Abstract][Full Text] [Related]
16. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
Maponga TG; Matteau Matsha R; Morin S; Scheibe A; Swan T; Andrieux-Meyer I; Spearman CW; Klein MB; Rockstroh JK
Hepatol Med Policy; 2017; 2():8. PubMed ID: 30288321
[TBL] [Abstract][Full Text] [Related]
17. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
Duffell EF; Hedrich D; Mardh O; Mozalevskis A
Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
[TBL] [Abstract][Full Text] [Related]
19. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
20. Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.
Spina A; Eramova I; Lazarus JV
BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S15. PubMed ID: 25252705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
